Skip to main content

Table 2b Hazard ratios for all-cause and CVD mortality by tertiles of NLR levels in subjects with prediabetes

From: Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study

NLR

Per 1 unit

increment

Tertiles of NLR levels

P for trend

Tertile 1

Tertile 2

Tertile 3

All-cause mortality

     

 No. deaths/total

1974/13,024

460/4397

584/4279

930/4348

 

  Not adjusted

1.40(1.33, 1.48)

1.00(ref)

1.17(0.97, 1.40)

1.83(1.59, 2.10)

<0.0001

   Model1

1.20(1.13, 1.28)

1.00(ref)

1.09(0.91, 1.29)

1.37(1.18, 1.59)

<0.0001

   Model2

1.18(1.11, 1.25)

1.00(ref)

1.06(0.90, 1.26)

1.33(1.14, 1.54)

<0.0001

   Model3

1.12(1.05, 1.19)

1.00(ref)

1.05(0.88, 1.24)

1.21(1.03, 1.43)

0.01

CVD mortality

     

 No. deaths/total

616/11,666

121/3911

177/3868

318/3887

 

  Not adjusted

1.60(1.47, 1.75)

1.00(ref)

1.32(0.96, 1.80)

2.36(1.82, 3.06)

<0.0001

   Model1

1.34(1.21, 1.48)

1.00(ref)

1.20(0.87, 1.64)

1.66(1.24, 2.21)

<0.0001

   Model2

1.33(1.20, 1.48)

1.00(ref)

1.18(0.86, 1.61)

1.66(1.24, 2.22)

<0.0001

   Model3

1.24(1.11, 1.37)

1.00(ref)

1.21(0.88, 1.67)

1.49(1.08, 2.04)

0.01

  1. Model 1: Adjusted for age (< 65 or > = 65years), sex (male or female), race/ethnicity (Hispanic Mexican, non-Hispanic black, non-Hispanic white, or others), marital status (married/Cohabitating, not married), family income-to-poverty ratio (< 1.0, 1.0–3.0, or ≥ 3.0), education level (less than high school, high school or equivalent, or college or above);
  2. Model 2: model 1 adjustments + BMI (< 30 or ≥ 30.0 kg/m2), smoking status (never, former, or current), drinking status (non-drinker or ever drinker), physical activity (low or high), HEI scores, cancer (no or yes);
  3. Model 3: model 2 adjustments + eGFR (< 30, 30–60, >=60 ml/min/1.73 m²), anemia (no or yes), hypertension (no or yes), hyperlipidemia (no or yes), depression (no or yes), COPD (no or yes), use of hypotensive drug (no or yes), use of lipid-lowering drug (no or yes)